Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1071-1080 of 2762 for

Edit search filters
  1. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

    Rochester, MN

  3. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

    Jacksonville, FL, Rochester, MN

  4. Evaluation of PCLs Using Three EUS-FNA Needles

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

    Rochester, MN, Jacksonville, FL, Scottsdale/Phoenix, AZ

  7. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression

    Rochester, MN

  8. Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Polyphenon E in Treating Patients with High-Risk of Colorectal Cancer

    Rochester, MN

  10. Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer